RNS Number : 6117Q
Cambium Global Timberland Limited
28 October 2021
 

28 October 2021

 

 

Cambium Global Timberland Limited

 

("Cambium" or "the Company")

 

Trading Update and Extension of Reporting Deadline

 

The Company provides the following update.

 

As has previously been reported, the sales of all the Company's interests in land have been concluded, leaving Cambium with only its interests in the related receivables (expected to be fully collected by February 2023) and its bank balances.

 

The Company continues to seek to keep costs to a minimum pending being able to complete the return of capital to shareholders.

 

Net Asset Value (NAV)

 

The Company expects the FY 2021 (30 April 2021) NAV to sit at or just above the level of £7 million (circa 9.7p per share) being a slight increase compared with the half year (31 October 2020) reported NAV of £6.5m (8.8p per share). This expected increase is due, in particular, to the crystallisation of sale prices and the additional receipt of proceeds from the release of the Lizarda lien, each as previously reported.

 

Extension of Reporting Deadline

 

Due to the Covid-19 impact, resulting in delays in the provision of information by our service provider in São Paulo, the Company will not be able to post its annual audited report and accounts for the financial year ended 30 April 2021 (the "Annual Report") to shareholders by 31 October 2021.

 

The Company has applied, pursuant to the guidance provided in "Inside AIM" on 27 January 2021, for an additional period to publish the Annual Report and has been granted an extension by AIM to publish by 30 November 2021. The Company expects to publish within the extension period granted.

 

 

Contacts

 

 

 

Cambium Global Timberland Limited

www.cambium.je

c/o Praxis Fund Services (Jersey) Limited

+44 (0)1534 835835

 

 

WH Ireland Limited

www.whirelandplc.com/

James Joyce / Darshan Patel

+44 (0) 20 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMPBBTMTATBFB